Search

Your search keyword '"Nancy Cook-Bruns"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Nancy Cook-Bruns" Remove constraint Author: "Nancy Cook-Bruns"
21 results on '"Nancy Cook-Bruns"'

Search Results

1. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

2. Stroke Outcomes in the COMPASS Trial

3. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

4. The future of clinical trials in secondary prevention after acute coronary syndromes

5. Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial

6. Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis

7. Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

8. Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial

9. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial

10. Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial

11. Agents with vasodilator properties in acute heart failure: how to design successful trials

12. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

13. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions

14. The treatment of missing data in a large cardiovascular clinical outcomes study

15. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis

16. Retrospective Analysis of the Safety of Herceptin® Immunotherapy in Metastatic Breast Cancer

17. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions

18. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

19. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis

20. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis

21. RIVAROXABAN IN THE SETTING OF CONTINUED DUAL ANTIPLATELET THERAPY: FINDINGS FROM THE ATLAS ACS 2-TIMI 51 TRIAL

Catalog

Books, media, physical & digital resources